
JBIO vs OMER
$JBIO vs $OMER head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
JBIO vs OMER: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·OMER is the weaker of the two on trend, below both its 50- and 200-day averages, while JBIO has held above one of them.
- ·Both beat the market over the past year: JBIO +22% and OMER +68%, against the S&P 500 at +8.8%.
- ·The last month has flipped the order: JBIO leads over the month (+0.4% against -15.1%) even though OMER leads over the year.
- ·JBIO sits closer to its support, 2.5% above it at $14.81, while OMER is 22.6% above its own at $10.80.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
JBIO vs OMER: the quick read
- ·OMER is the larger company by market cap ($1.08B vs $1.07B).
- ·JBIO has been more active on our scanner (140 vs 118 alerts in 30 days).
- ·JBIO has the smaller float (55.7M vs 68.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 140 and 118 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·OMER is the one in play today, trading about 2.1x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Watching JBIO or OMER? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing JBIO and OMER on TheDesperateTrader.
- Is JBIO or OMER the better stock?
- "Better" depends on your goal, and these two are not alike. OMER is the larger company by market cap ($1.08B vs $1.07B). JBIO has been more active on our scanner (140 vs 118 alerts in 30 days). JBIO has the smaller float (55.7M vs 68.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between JBIO and OMER?
- The differences that matter: they are not in the same business - JBIO is pharmaceutical preparations and OMER is pharmaceutical preparations; they are similar in size ($1.07B vs $1.08B); they trade at very different share prices ($15.19 vs $13.95); JBIO sits at 25% of its 52-week range against 50% for OMER; our scanner flagged JBIO 140 times in the last 30 days against 118 for OMER. Everything above is measured from the latest completed session and SEC filings.
- Which of JBIO and OMER is more active right now?
- Right now JBIO is at about 0.9x its normal volume and OMER is at about 2.1x, so OMER is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is JBIO or OMER in the stronger trend?
- JBIO is above its 50-day average of $15.00 and below its 200-day average of $18.21; OMER is below its 50-day average of $17.92 and below its 200-day average of $13.83. They split the head-to-head evenly, 2 measures each (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading JBIO or OMER? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore JBIO and OMER comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.